460 related articles for article (PubMed ID: 26931513)
1. Therapy-induced microenvironmental changes in cancer.
Ma Y; Yang H; Pitt JM; Kroemer G; Zitvogel L
J Mol Med (Berl); 2016 May; 94(5):497-508. PubMed ID: 26931513
[TBL] [Abstract][Full Text] [Related]
2. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
[TBL] [Abstract][Full Text] [Related]
3. Damage-associated molecular patterns in cancer: a double-edged sword.
Hernandez C; Huebener P; Schwabe RF
Oncogene; 2016 Nov; 35(46):5931-5941. PubMed ID: 27086930
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
Mooradian MJ; Sullivan RJ
Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
[TBL] [Abstract][Full Text] [Related]
5. Adapting conventional cancer treatment for immunotherapy.
Qiao J; Liu Z; Fu YX
J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
[TBL] [Abstract][Full Text] [Related]
6. Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies.
Ngiow SF; Young A
Front Immunol; 2020; 11():1633. PubMed ID: 32849557
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
8. Immune biological rationales for the design of combined radio- and immunotherapies.
Hader M; Frey B; Fietkau R; Hecht M; Gaipl US
Cancer Immunol Immunother; 2020 Feb; 69(2):293-306. PubMed ID: 31953578
[TBL] [Abstract][Full Text] [Related]
9. Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma.
Martinez-Zubiaurre I; Chalmers AJ; Hellevik T
Front Immunol; 2018; 9():1679. PubMed ID: 30105016
[TBL] [Abstract][Full Text] [Related]
10. The fundamental role of mechanical properties in the progression of cancer disease and inflammation.
Mierke CT
Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689
[TBL] [Abstract][Full Text] [Related]
11. Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity
van den Bijgaart RJE; Schuurmans F; Fütterer JJ; Verheij M; Cornelissen LAM; Adema GJ
Front Immunol; 2021; 12():617365. PubMed ID: 33936033
[No Abstract] [Full Text] [Related]
12. Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies.
Frey B; Rubner Y; Wunderlich R; Weiss EM; Pockley AG; Fietkau R; Gaipl US
Curr Med Chem; 2012; 19(12):1751-64. PubMed ID: 22414083
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy.
Mohamed E; Cao Y; Rodriguez PC
Cancer Immunol Immunother; 2017 Aug; 66(8):1069-1078. PubMed ID: 28577085
[TBL] [Abstract][Full Text] [Related]
14. Tumor Microenvironment as A "Game Changer" in Cancer Radiotherapy.
Jarosz-Biej M; Smolarczyk R; Cichoń T; Kułach N
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261963
[TBL] [Abstract][Full Text] [Related]
15. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy.
Meng MB; Wang HH; Cui YL; Wu ZQ; Shi YY; Zaorsky NG; Deng L; Yuan ZY; Lu Y; Wang P
Oncotarget; 2016 Aug; 7(35):57391-57413. PubMed ID: 27429198
[TBL] [Abstract][Full Text] [Related]
16. The multi-faceted roles of prostaglandin E2 in cancer-infiltrating mononuclear phagocyte biology.
Sha W; Brüne B; Weigert A
Immunobiology; 2012 Dec; 217(12):1225-32. PubMed ID: 22727331
[TBL] [Abstract][Full Text] [Related]
17. Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance.
Traba J; Sack MN; Waldmann TA; Anton OM
Front Immunol; 2021; 12():657293. PubMed ID: 34079545
[TBL] [Abstract][Full Text] [Related]
18. Immune suppression and reversal of the suppressive tumor microenvironment.
Shimizu K; Iyoda T; Okada M; Yamasaki S; Fujii SI
Int Immunol; 2018 Sep; 30(10):445-454. PubMed ID: 29939325
[TBL] [Abstract][Full Text] [Related]
19. The renaissance of anti-neoplastic immunity from tumor cell demise.
Ma Y; Pitt JM; Li Q; Yang H
Immunol Rev; 2017 Nov; 280(1):194-206. PubMed ID: 29027231
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape.
Wellenstein MD; de Visser KE
Immunity; 2018 Mar; 48(3):399-416. PubMed ID: 29562192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
